F2R and neoplasm: Importantly, PAR-1 expression was also detected in multiple cancer subtypes, including epithelial carcinomas, melanoma, glioblastoma (GBM), giant cell tumors and sarcoma, and is present on both malignant cells as well as on tumor-associated stromal components (reviewed in [16,57]).